FcγRIIa, IIIa and IIIb gene polymorphisms in Behçet's disease: Do they have any clinical implications?

Clinical and Experimental Rheumatology

Volumn 26, Issue 4 SUPPL. 50, 2008, Pages

  Aksu, Kenan ^a,b   Kitapcioglu, Gul ^a   Keser, Gokhan ^a   Berdeli, Afig ^a   Karabulut, Gonca ^a   Kobak, Senol ^a   Ozmen, Mustafa ^a   Inal, Vedat ^a   Kabasakal, Yasemin ^a   Oksel, Fahrettin ^a   Kocanaogullari, Hayriye ^a   Doganavsargil, Eker ^a  

^a EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b NONE   (Turkey)

Author keywords

Beh et's disease; Fc receptor

Indexed keywords

FC RECEPTOR IIA; FC RECEPTOR IIIA; FC RECEPTOR IIIB; IMMUNOGLOBULIN RECEPTOR; UNCLASSIFIED DRUG; FC RECEPTOR; FCGR3A PROTEIN, HUMAN; FCGR3B PROTEIN, HUMAN;

ADULT; ARTHRITIS; ARTICLE; BEHCET DISEASE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENOTYPE; GENOTYPE PHENOTYPE CORRELATION; HUMAN; INFLAMMATORY DISEASE; MAJOR CLINICAL STUDY; MALE; ONSET AGE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECEPTOR GENE; SYSTEMIC DISEASE; SYSTEMIC VASCULITIS; TURKEY (REPUBLIC); VASCULAR DISEASE; ADOLESCENT; AGED; GENETICS; MIDDLE AGED; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; AGED; BEHCET SYNDROME; CROSS-SECTIONAL STUDIES; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, IGG; YOUNG ADULT;

EID: 55049115440     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. YAZICI H, YURDAKUL S, HAMURYUDAN V, FRESKO I: Behçet's syndrome. In: Textbook of Rheumatology, 3rd ed., New York, Mosby, 2003: 1665-9.
2. MIZUSHIMA Y: Chemotaxis and phagocytosis of leucocytes in Behçet's disease: An overview. In LEHNER T and BARNES CG (Eds.): Recent Advances in Behçet's Disease. London, Royal Society of Medicine Services, 1986: 85-7.
3. KANSU E, SIVRI B, SAHIN G et al.: Endothelial cell dysfunction in Behcet's disease. In: O'DUFFY JD and KOKMEN E (Eds.): Behçet's Disease - Basic and Clinical Aspects. New York, Marcel Dekker, 1991: 523-30.
4. SAHIN S, AKOGLU T, DIRESKENELI H, SEN LS, LAWRENCE R: Neutrophil adhesion to endothelial cells and factors affecting adhesion in patients with Behçet's disease. Ann Rheum Dis 1996; 55: 129-33.
5. GÜL A: Behçet's disease: An update on the pathogenesis. Clin Exp Rheumatol 2001: 24 (Suppl. 24): S6-12.
6. DIRESKENELI H: Autoimmunity vs autoinflammation in Behçet's disease: Do we over-simplify a complex disorder? Rheumatology (Oxford) 2006; 45: 1461-5.
7. HIROHATA S, HASHIMATO T: Abnormal T cell responses to bacterial superantigens in Behçet's disease. Clin Exp Immunol 1998; 112: 17-24.
8. MUMCU G, ERGUN T, ELBIR Y et al.: Clinical and immunological effects of azithromycin in Behçet's disease. J Oral Pathol Med 2005; 34: 13-6.
9. SALMON JE, PRICOP L: Human receptors for immunoglobulin G. Arthritis Rheum 2001; 44: 739-50.
10. KIMBERLY RP, WU J, GIBSON AW et al.: Diversity and duplicity. Immunologic Research 2002; 26: 55-67.
11. MORGAN AW, ROBINSON JI, BARRETT JH et al.: Association of FCGR2A and FCGR2A-FCGR3A haplotypes with susceptibility to giant cell arteritis. Arthritis Res Ther 2006; 8: R109.
12. INTERNATIONAL STUDY GROUP FOR BEHÇET'S DISEASE: Evaluation of diagnostics ('classification') criteria in Behçet's disease - towards internationally agreed criteria. Br J Rheumatol 1992; 31: 299-308.
13. KRAUSE I, MADER R, SULKES J et al.: Behçet's disease in Israel: The influence of ethnic origin on disease expression and severity. J Rheumatol 2001; 28: 1033-6.
14. FLESCH BK, BAUER F, NEPPERT J: Rapid typing of the human Fcγ receptor IIA polymorphism by polymerase chain reaction amplification with allele-specific primers. Transfusion 1998; 38: 174-6.
15. WU J, EDBERG JC, REDECHA PB et al.: A novel polymorphism of FcγRIIIa (CD16) alters receptor function and predisposes to autoimmune disease. J Clin Invest 1997; 100: 1059-70.
16. BUX J, STEIN EL, SANTOSO S, MUELLER-ECKHARDT C: NA gene frequencies in the German population, determined by the polymerase chain reaction with sequence-specific primers. Transfusion 1995; 35: 54-7.
17. TAKAI T: Fc receptors and their role in immune regulation and autoimmunity. J Clin Immunol 2005; 1: 1-18.
18. GÜL A: Behçet's disease as an autoinflammatory disorder. Curr Drug Target Inflam & Allerg 2005; 4: 81-3.
19. NIMMERJAHN F, RAVETCH JV: Fc receptors as regulators of immunity. Adv Immunol 2007; 96: 179-204.
20. DEMIRALP-EKSIOGLU E, DIRESKENELI H, KIBAROGLU A, YAVUZ S, ERGUN T, AKOGLU T: Neutrophil activation in Behçet's disease. Clin Exp Rheumatol 2001; 19 (Suppl. 24): S19-S24.
21. URETEN K, ERTENLI I, OZTURK MA et al.: Neutrophil CD64 expression in Behçet's disease. J Rheumatol 2005; 32: 849-52.
22. MORGAN AW, KEYTE VH, BABBAGE SJ et al.: FcγRIIIA-158V and rheumatoid arthritis: A confirmation study. Rheumatology 2003; 42: 528-33.
23. HULETT MD, HOGARTH PM: Molecular basis of Fc receptor function. Adv Immunol 1994; 57: 1-127.
24. SALMON JE, MILLARD SS, BROGLE NL, KIMBERLY RP: Fc gamma receptor IIIb enhances Fc gamma receptor IIa function in an oxidant-dependent and allele-sensitive manner. J Clin Invest 1995; 95: 2877-85.
25. VAN SORGE NM, VAN DER POL W-M, VAN DE WINKEL: FcγR polymorphisms: implications for function, disease susceptibility and immunotherapy. Tissue Antigens 2003; 61: 189-202.
26. VEDELER CA, MYHR KM, NYLAND HA Fc receptors for immunoglobulin G: a role in the pathogenesis of Guillain-Barré syndrome and multiple sclerosis. J Neuroimmunol 2001; 118: 187-93.
27. MYHR KM, RAKNES G, NYLAND H, VEDELER C: Immunoglobulin G Fc-receptor (FcγR) IIA and IIIB polymorphisms related to disability in multiple sclerosis. Neurology 1999; 52: 1771-6.